Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Gynecol Oncol. 2011 Oct 28;124(3):569–574. doi: 10.1016/j.ygyno.2011.10.022

Table 3.

Expression of biomarkers in pre-treatment tumor specimens.a

Biomarker n Lower quartile Median Upper quartile
pERK (H-value) 19 0.00 0.05 0.70
Ki-67 (H-Value) 19 1.40 1.80 2.10
pERK (Percentage) 19 0% 5% 60%
pERK (Percentage) 19 60% 60% 70%

No significant EGFR or Her/neu was detected.

a

Immunohistochemistry H-value or percentage staining positive.